Bardy Diagnostics, Inc. was founded to address the long-standing complaint in cardiac arrhythmia monitoring that traditional monitors were bulky, uncomfortable, and typically recorded noisy QRS heart rhythm signals.
CAM™ is the first P-wave centric ECG monitor™ – a single patient use monitor that unobtrusively records continuously up to 7 days. This focus on the P-wave is a major new tool for cardiologists and cardiac rhythm specialists for accurately diagnosing arrhythmias.
The CAM is the size of an adhesive bandage and can be worn during exercise, sleep, and showering. It is also designed to to be comfortable for women to wear, with its narrow, hourglass shape. The Carnation Ambulatory Monitor's patented center chest placement, above the atria and away from noisy muscle stimulation, provides optimal signal detection.
CAM™ is the first P-wave centric ECG monitor™ – a single patient use monitor that unobtrusively records continuously up to 7 days. This focus on the P-wave is a major new tool for cardiologists and cardiac rhythm specialists for accurately diagnosing arrhythmias.
The CAM is the size of an adhesive bandage and can be worn during exercise, sleep, and showering. It is also designed to to be comfortable for women to wear, with its narrow, hourglass shape. The Carnation Ambulatory Monitor's patented center chest placement, above the atria and away from noisy muscle stimulation, provides optimal signal detection.
Location: United States, Washington, Bellevue
Employees: 51-200
Total raised: $35.5M
Founded date: 2013
Investors 9
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.04.2019 | Series B | $35.5M | - |
Mentions in press and media 31
| Date | Title | Description |
| 07.04.2026 | American Heart Association Ventures: Interview With Managing Director Lisa Suennen About The Health-Focused Firm | American Heart Association Ventures invests in mission-aligned companies to translate evidence-based science and technologies into sustainable products that improve cardiovascular and brain health. Pulse 2.0 interviewed American Heart Assoc... |
| 19.01.2021 | Health tech giant Hillrom to acquire Seattle startup Bardy Diagnostics for $375M | Dr. Gust Bardy, founder of Bardy Diagnostics. (Bardy Photo) Hillrom, a publicly-traded medical device and digital health company based in Chicago, will pay $375 million to acquire Seattle startup Bardy Diagnostics. Founded in 2013, Bardy se... |
| 08.09.2020 | Bardy Diagnostics® Announces Appointment of Kevin Hykes as President and Chief Executive Officer | SEATTLE, Sept. 8, 2020 /PRNewswire/ -- Bardy Diagnostics, Inc., ("BardyDx"), a leading developer and provider of remote ambulatory cardiac monitoring and digital health solutions, announced today the appointment of Kevin Hykes as ... |
| 25.03.2020 | Bardy Diagnostics™ Announces Use of The Carnation Ambulatory Monitor Patch to Measure QT Segments in COVID-19 Patients Using Hydroxychloroquine | Written by bardy-admin |
| 23.01.2020 | Bardy Diagnostics™ Commercially Launches its 14-Day CAM™ Patch | SEATTLE /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today the commercial launch of the 14-Day version of the Carnation Ambulatory... |
| 13.01.2020 | Bardy Diagnostics™ Appoints Ed Vertatschitsch as COO | SEATTLE / PRNewswire / — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the only P-wave centric™ ambulat... |
| 13.01.2020 | Bardy Diagnostics™ Names Ed Vertatschitsch as Chief Operating Officer and Announces Additions to the Leadership Team | SEATTLE, Jan. 13, 2020 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the only P-wave cen... |
| 25.10.2019 | Bardy Diagnostics Wins Digital Health Pitch Session at ESC Congress 2019 | SEATTLE /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that it was selected as winner of the “Remote Monitoring in Arrhythmias” Tech... |
| 14.10.2019 | Top 10 VCs investing in medical device companies | They include NEA, Versant Ventures, SOSV and Innova Memphis Healthtech is a big and broad space, so much so that there are whole subsectors that see more investments than entire industries. Medical device companies, for example, raised $2.9... |
| 06.09.2019 | Bardy Diagnostics™ Receives 510(k) Clearance from U.S. FDA for its 14-Day CAM™ patch | SEATTLE, Sept. 6, 2019 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today it received 510(k) clearance from the U.S. Food and Drug... |
Show more